About us
Innovation, science, and technology to improve the lives of more and more people.
Who we are
+20 years of proven excellence and experience
Founded in 2005 as a center for Pharmaceutical Bioequivalence, Synvia has established itself as the largest clinical research company in Latin America, resulting from sustained expansion in scientific excellence, cutting-edge infrastructure, and global regulatory compliance.
With an integrated presence at all stages of the pharmaceutical chain, the company has become a reference for those seeking quality, agility, and trust in their projects.
+200 pharmaceutical companies in Brazil and around the world trust Synvia
From clinical research to laboratory analyses, toxicology, and digital solutions for study management, a unique structure that ensures efficiency, traceability, and regulatory compliance aligned with the major global agencies (ANVISA, EMA, and FDA).
+2,000 clinical studies conducted
Synvia conducts clinical and bioanalytical studies with complete infrastructure and a team specialized in various therapeutic areas, ensuring compliance with the highest international regulatory standards (ANVISA, EMA, and FDA).
+800 multidisciplinary professionals
More than 800 professionals, including dozens holding master's and doctoral degrees, as well as specialists, make up the multidisciplinary team that underpins Synvia's scientific and operational excellence.
In addition to technical and laboratory areas, we have highly qualified corporate structures that together ensure the integration between science, processes, and results with the highest standard of the pharmaceutical industry.
+30 LC–MS/MS: The largest analytical park in Latin America in mass spectrometry
With more than 30 LC–MS/MS systems, Synvia's analytical park is the largest and most advanced in Latin America in mass spectrometry.
Equipped with state-of-the-art technology and high-sensitivity infrastructure, the laboratory conducts bioanalytical and pharmaceutical equivalence analyses with precision, traceability, and full regulatory compliance.
+20,000 m² of proprietary and specialized infrastructure
Excellence, quality, and global compliance
We operate according to standards recognized by the leading global agencies, with results that inspire confidence, broaden horizons, and drive the competitiveness of the global pharmaceutical industry.
